Cargando…
Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity
BACKGROUND: Retinopathy of prematurity (ROP) is a vasoproliferative retinal disease in premature infants that causes lifetime visual impairment and blindness in the early ages. In this study, we investigated the differences in the values of clinical laboratory parameters between different ROP and it...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301226/ https://www.ncbi.nlm.nih.gov/pubmed/35919643 http://dx.doi.org/10.22088/cjim.13.2.10 |
_version_ | 1784751381959147520 |
---|---|
author | Rasoulinejad, Seyed Ahmad Maroufi, Faezeh Alizadeh, Ahad |
author_facet | Rasoulinejad, Seyed Ahmad Maroufi, Faezeh Alizadeh, Ahad |
author_sort | Rasoulinejad, Seyed Ahmad |
collection | PubMed |
description | BACKGROUND: Retinopathy of prematurity (ROP) is a vasoproliferative retinal disease in premature infants that causes lifetime visual impairment and blindness in the early ages. In this study, we investigated the differences in the values of clinical laboratory parameters between different ROP and its remission/progression statuses regarding stages and zones. METHODS: This historical cohort study includes 828 infants divided into two groups after the first examination containing ROP infants and controls. The biochemical and hematological parameters of the two groups have been collected from the patient’s history. RESULTS: In infants with ROP, the hematopoiesis-related parameters, including the mean level of hemoglobin, total bilirubin, potassium, calcium were significantly less than controls (P=0.039, P=0.001, P=0.001, and P=0.046, respectively). The percentages of reticulocyte and the levels of BUN in ROP patients were significantly higher than in normal infants (P=0.015 and p <0.001, respectively). Moreover, the levels of hemoglobin and BUN were significantly different in the different zones of ROP (P=0.017 and P=0.001, respectively). Also, higher hemoglobin levels, total bilirubin, and CRP were observed in the reduced stages of ROP (P=0.041, P=0.045, and P=0.039, respectively). CONCLUSION: Laboratory parameters are different in different stages, zones and remission/ progression ROP infants. |
format | Online Article Text |
id | pubmed-9301226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Babol University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-93012262022-08-01 Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity Rasoulinejad, Seyed Ahmad Maroufi, Faezeh Alizadeh, Ahad Caspian J Intern Med Original Article BACKGROUND: Retinopathy of prematurity (ROP) is a vasoproliferative retinal disease in premature infants that causes lifetime visual impairment and blindness in the early ages. In this study, we investigated the differences in the values of clinical laboratory parameters between different ROP and its remission/progression statuses regarding stages and zones. METHODS: This historical cohort study includes 828 infants divided into two groups after the first examination containing ROP infants and controls. The biochemical and hematological parameters of the two groups have been collected from the patient’s history. RESULTS: In infants with ROP, the hematopoiesis-related parameters, including the mean level of hemoglobin, total bilirubin, potassium, calcium were significantly less than controls (P=0.039, P=0.001, P=0.001, and P=0.046, respectively). The percentages of reticulocyte and the levels of BUN in ROP patients were significantly higher than in normal infants (P=0.015 and p <0.001, respectively). Moreover, the levels of hemoglobin and BUN were significantly different in the different zones of ROP (P=0.017 and P=0.001, respectively). Also, higher hemoglobin levels, total bilirubin, and CRP were observed in the reduced stages of ROP (P=0.041, P=0.045, and P=0.039, respectively). CONCLUSION: Laboratory parameters are different in different stages, zones and remission/ progression ROP infants. Babol University of Medical Sciences 2022 /pmc/articles/PMC9301226/ /pubmed/35919643 http://dx.doi.org/10.22088/cjim.13.2.10 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Rasoulinejad, Seyed Ahmad Maroufi, Faezeh Alizadeh, Ahad Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title | Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title_full | Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title_fullStr | Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title_full_unstemmed | Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title_short | Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
title_sort | clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301226/ https://www.ncbi.nlm.nih.gov/pubmed/35919643 http://dx.doi.org/10.22088/cjim.13.2.10 |
work_keys_str_mv | AT rasoulinejadseyedahmad clinicalparametersindifferentstageszonesandremissionprogressionstatusesofretinopathyofprematurity AT maroufifaezeh clinicalparametersindifferentstageszonesandremissionprogressionstatusesofretinopathyofprematurity AT alizadehahad clinicalparametersindifferentstageszonesandremissionprogressionstatusesofretinopathyofprematurity |